{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:40:07Z","timestamp":1793785207369,"version":"4.6.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Antihypertensive medication use patterns have likely been influenced by changing costs and accessibility over the past 3 decades. This study examines the relationships between patent exclusivity loss, medication costs, and national health policies on antihypertensive medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Using 1996 to 2021 Medical Expenditure Panel Survey data of US adults with hypertension taking at least 1 antihypertensive medication, we conducted a cross-sectional analysis. We explored the associations between patent exclusivity loss, per-pill costs, and Medicare Part D enactment on medication use over time, focusing on the most commonly used medications (lisinopril, amlodipine, losartan, hydrochlorothiazide, and metoprolol).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The unweighted sample comprised 50\u2009095 US adults (mean age, 62 years; 53% female). The survey-weighted number of adults taking antihypertensive medications increased from 22 million (95% CIs, 20\u201323 million) to 55 million (95% CI, 51\u201360 million) between 1996 and 2021. Loss of patent exclusivity led to increased medication fills, notably for lisinopril, amlodipine, and losartan, which all exhibited within-class dominance. However, per-pill cost decreases coinciding with Medicare Part D did not increase the number of individuals treated or the use of specific antihypertensive medications or classes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The increase in antihypertensive medication use over the past decades highlights the significant impact of loss of patent exclusivity on the uptake in the use of specific medications. These findings underscore the complexity of factors influencing medication use, beyond cost reductions alone, and suggest that policies need to consider multiple facets to effectively improve antihypertensive medication accessibility and utilization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/hypertensionaha.124.23509","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:03:54Z","timestamp":1725426234000},"page":"2307-2317","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021"],"prefix":"10.1161","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-9060","authenticated-orcid":true,"given":"Joshua A.","family":"Jacobs","sequence":"first","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City (J.A.J., C.G.D., J.B.K., A.P.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-1896","authenticated-orcid":true,"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, Australia (A.R., N.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-6047","authenticated-orcid":true,"given":"Brandon K.","family":"Bellows","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Columbia University Medical Center, New York (B.K.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0118-4986","authenticated-orcid":true,"given":"Inmaculada","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla (I.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Wang","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, University of New South Wales, Sydney, Australia (A.R., N.W.)."},{"name":"Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (N.W.)."},{"name":"Sydney Medical School, University of Sydney, New South Wales, Australia (N.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7382-4607","authenticated-orcid":true,"given":"Catherine G.","family":"Derington","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City (J.A.J., C.G.D., J.B.K., A.P.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-7951","authenticated-orcid":true,"given":"Jordan B.","family":"King","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City (J.A.J., C.G.D., J.B.K., A.P.B.)."},{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora (J.B.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-782X","authenticated-orcid":true,"given":"Alexander R.","family":"Zheutlin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, IL (A.R.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-383X","authenticated-orcid":true,"given":"Paul K.","family":"Whelton","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA (P.K.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-5875","authenticated-orcid":true,"given":"Brent M.","family":"Egan","sequence":"additional","affiliation":[{"name":"Improving Health Outcomes, American Medical Association, Greenville, SC (B.M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-2972","authenticated-orcid":true,"given":"William C.","family":"Cushman","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis (W.C.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-5039","authenticated-orcid":true,"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City (J.A.J., C.G.D., J.B.K., A.P.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09801"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.650"},{"key":"e_1_3_3_5_2","unstructured":"Fryar CD Ostchega Y Hales CM Zhang G Kruszon-Moran D. Hypertension prevalence and control among adults: 2015\u20132016 United States NCHS data brief no 289. Hyattsville MD: National Center for Health Statistics; 2017."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14545"},{"key":"e_1_3_3_7_2","unstructured":"U.S. Department of Health and Human Services. Healthy People - Healthy People 2020. 2023. Accessed January 31 2024. https:\/\/www.cdc.gov\/nchs\/healthy_people\/hp2020.htm"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2019.02.019"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-1993-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611179"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2010.01183.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19222"},{"key":"e_1_3_3_13_2","unstructured":"Food and Drug Administration. FDALabel. Accessed June 3 2024. https:\/\/nctr-crs.fda.gov\/fdalabel\/ui\/spl-summaries\/criteria\/626753"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14360"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.096156"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07612-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx085"},{"key":"e_1_3_3_19_2","unstructured":"Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey Home. Accessed December 18 2023. https:\/\/meps.ahrq.gov\/\/mepsweb\/"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.5034\/inquiryjrnl_48.03.04"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06214-1"},{"key":"e_1_3_3_22_2","unstructured":"S Bureau of Economic Analysis. Table 2.4.4U. Price Indexes for Personal Consumption Expenditures by Type of Product. 2022. Accessed January 29 2024. https:\/\/apps.bea.gov\/iTable\/?reqid=19&step=2&isuri=1&categories=underlying#eyJhcHBpZCI6MTksInN0ZXBzIjpbMSwyLDNdLCJkYXRhIjpbWyJjYXRlZ29yaWVzIiwiU3VydmV5Il0sWyJOSVBBX1RhYmxlX0xpc3QiLCIyMDE2Il1dfQ=="},{"key":"e_1_3_3_23_2","unstructured":"United States Census Bureau. S0101: AGE AND SEX - Census Bureau Table. Accessed June 4 2024. https:\/\/data.census.gov\/table\/ACSST1Y2019.S0101?q=age%20and%20sex%20distribution"},{"key":"e_1_3_3_24_2","unstructured":"R Foundation. R: The R Project for Statistical Computing. 2024. Accessed April 13 2022. https:\/\/www.r-project.org\/"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16667"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21132"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.15.1850"},{"key":"e_1_3_3_28_2","article-title":"Wal-mart to sell generic drugs for $4.","author":"Silberner J","year":"2006","unstructured":"Silberner J. Wal-mart to sell generic drugs for $4. NPR. 2006. Accessed February 15, 2024. https:\/\/www.npr.org\/2006\/09\/21\/6119292\/wal-mart-to-sell-generic-drugs-for-4","journal-title":"NPR"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015302"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18116"},{"key":"e_1_3_3_31_2","article-title":"Relief for some but maybe not many in wal-mart plan for $4 generic drugs.","author":"Barbaro M","year":"2006","unstructured":"Barbaro M, Abelson R. Relief for some but maybe not many in wal-mart plan for $4 generic drugs. The New York Times. 2006. Accessed February 15, 2024. https:\/\/www.nytimes.com\/2006\/09\/22\/business\/22generic.html","journal-title":"The New York Times"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.8.893"},{"key":"e_1_3_3_33_2","first-page":"e265","article-title":"Impact of formulary restrictions on medication use and costs.","volume":"23","author":"Shen X","year":"2017","unstructured":"Shen X, Stuart BC, Powers CA, Tom SE, Magder LS, Perfetto EM. Impact of formulary restrictions on medication use and costs. Am J Manag Care. 2017;23:e265\u2013e274.","journal-title":"Am J Manag Care"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28510"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1785"},{"key":"e_1_3_3_38_2","unstructured":"National Committee for Quality Assurance. Healthcare Effectiveness Data and Information Set (HEDIS) - Healthy People 2030. Accessed February 15 2024. https:\/\/health.gov\/healthypeople\/objectives-and-data\/data-sources-and-methods\/data-sources\/healthcare-effectiveness-data-and-information-set-hedis"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7400.1211"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.47787"}],"updated-by":[{"DOI":"10.1161\/hyp.0000000000000268","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000}}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.124.23509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:21:06Z","timestamp":1750782066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.124.23509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.124.23509"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.124.23509","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}